(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 30.67%91.43B | 47.60%42.86B | 26.12%173.21B | 20.13%119.5B | 12.61%69.97B | -13.63%29.04B | 0.69%137.34B | 9.56%99.48B | 0.33%62.13B | 8.04%33.62B |
Operating income | 30.67%91.43B | 47.60%42.86B | 26.12%173.21B | 20.13%119.5B | 12.61%69.97B | -13.63%29.04B | 0.69%137.34B | 9.56%99.48B | 0.33%62.13B | 8.04%33.62B |
Operating expenses | -24.56%-72.47B | -40.62%-34.27B | -27.12%-140.77B | -21.74%-96.98B | -14.72%-58.18B | 12.47%-24.37B | 3.17%-110.74B | -5.19%-79.67B | 2.22%-50.71B | -5.43%-27.84B |
Gross profit | 60.82%18.96B | 84.03%8.59B | 21.95%32.44B | 13.66%22.52B | 3.24%11.79B | -19.21%4.67B | 20.71%26.6B | 31.57%19.81B | 13.48%11.42B | 22.72%5.78B |
Selling expenses | -16.96%-3.81B | -17.32%-1.71B | -41.00%-8.29B | -32.53%-5.11B | -46.80%-3.25B | -38.31%-1.45B | -13.17%-5.88B | 1.39%-3.85B | 9.34%-2.22B | 8.09%-1.05B |
Administrative expenses | 3.45%-2B | 5.48%-1B | 3.24%-4.74B | 10.61%-3.09B | 6.43%-2.07B | 9.97%-1.06B | -21.03%-4.89B | -43.33%-3.46B | -65.03%-2.21B | -77.51%-1.18B |
Research and development expenses | -19.24%-4.18B | -27.73%-1.96B | -24.97%-8.05B | -16.88%-5.5B | -10.48%-3.51B | -15.92%-1.53B | -43.56%-6.45B | -64.79%-4.71B | -70.99%-3.18B | -45.77%-1.32B |
Profit from asset sales | -708.25%-17.41M | -121.58%-18.03M | -97.95%99.59K | 92.06%-3.66M | 93.16%-2.15M | -113.51%-8.14M | 117.55%4.86M | -229.82%-46.13M | -31.01%-31.48M | 64.88%-3.81M |
Revaluation surplus | 152.62%69.68M | -36.06%30.01M | -151.72%-26.04M | -61.42%69.88M | -8.63%-132.42M | 349.78%46.94M | -83.57%50.34M | 7.37%181.12M | -232.89%-121.91M | -309.42%-18.79M |
-Changes in the fair value of other assets | 152.62%69.68M | -36.06%30.01M | -151.72%-26.04M | -61.42%69.88M | -8.63%-132.42M | 349.78%46.94M | -83.57%50.34M | 7.37%181.12M | -232.89%-121.91M | -309.42%-18.79M |
Impairment and provision | 30.73%-220.7M | 68.11%-56.94M | -51.62%-550.08M | -270.15%-389.43M | -277.12%-318.59M | -808.59%-178.52M | 38.82%-362.81M | 67.07%-105.21M | 70.46%-84.48M | 226.38%25.19M |
-Other impairment is provision | 30.73%-220.7M | 68.11%-56.94M | -51.62%-550.08M | -270.15%-389.43M | -277.12%-318.59M | -808.59%-178.52M | 38.82%-362.81M | 67.07%-105.21M | 70.46%-84.48M | 226.38%25.19M |
Special items of operating profit | 184.75%2.55B | 228.65%1.35B | 49.39%2.27B | 23.21%1.36B | 5.79%896.34M | -9.70%409.4M | -29.44%1.52B | -37.94%1.11B | -26.16%847.32M | -31.15%453.39M |
Operating profit | 695.96%7.97B | 6,452.64%3.73B | 29.13%7.08B | 6.24%5.63B | -57.74%1B | -103.60%-58.66M | -7.45%5.48B | 8.65%5.3B | -33.27%2.37B | -7.61%1.63B |
Financing cost | -28.38%160.12M | -683.59%-93.98M | -94.94%125.89M | -110.08%-276.69M | -92.38%223.57M | 95.88%-11.99M | 454.93%2.49B | 587.29%2.74B | 856.93%2.93B | -396.73%-290.83M |
Special items of earning before tax | -6.86%155.44M | -5.68%125.33M | -25.78%623.09M | -67.28%247.08M | -70.36%166.9M | -73.74%132.88M | -24.59%839.55M | 373.88%755.14M | 631.21%563.05M | 1,519.39%506M |
Earning before tax | 495.39%8.29B | 5,939.60%3.76B | -11.16%7.82B | -36.35%5.6B | -76.27%1.39B | -96.63%62.22M | 17.70%8.81B | 61.85%8.8B | 49.05%5.87B | -2.56%1.85B |
Tax | -3,988.05%-1.21B | -567.96%-530.76M | -44.69%-801.24M | 7.20%-604.98M | 89.20%-29.6M | 152.76%113.42M | 26.86%-553.74M | -32.31%-651.89M | 32.65%-274.2M | 15.97%-214.97M |
After-tax profit from continuing operations | 419.52%7.08B | 1,737.35%3.23B | -14.90%7.02B | -38.68%5B | -75.63%1.36B | -89.24%175.64M | 22.72%8.25B | 64.80%8.15B | 58.47%5.59B | -0.46%1.63B |
Earning after tax | 419.52%7.08B | 1,737.35%3.23B | -14.90%7.02B | -38.68%5B | -75.63%1.36B | -89.24%175.64M | 22.72%8.25B | 64.80%8.15B | 58.47%5.59B | -0.46%1.63B |
Minority profit | -40.19%825.49K | -140.86%-575.91K | 109.47%1.25M | 120.74%2.35M | 116.01%1.38M | 168.66%1.41M | -1,126.11%-13.23M | ---11.34M | ---8.62M | ---2.05M |
Profit attributable to shareholders | 419.99%7.08B | 1,752.55%3.23B | -15.06%7.02B | -38.79%4.99B | -75.69%1.36B | -89.34%174.23M | 22.90%8.27B | 65.03%8.16B | 58.72%5.6B | -0.34%1.63B |
Basic earnings per share | 418.75%0.83 | 1,800.00%0.38 | -9.89%0.82 | -33.71%0.59 | -73.77%0.16 | -88.89%0.02 | 24.66%0.91 | 64.81%0.89 | 56.41%0.61 | 0.00%0.18 |
Diluted earnings per share | 418.75%0.83 | 1,800.00%0.38 | -9.89%0.82 | -32.95%0.59 | -73.33%0.16 | -88.89%0.02 | 24.66%0.91 | 62.96%0.88 | 57.89%0.6 | 0.00%0.18 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Deloitte & Touche Certified Public Accountants Limited | -- | -- | -- | Deloitte & Touche Certified Public Accountants Limited | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data